Raymond James Financial’s Colgate-Palmolive CL Stock Holding History

Raymond James Financial’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$110M	Buy	1,294,562 +14,960	+1%	+$1.35M	0.03%	517
2026 Q2	$117M	Sell	1,279,602 -71,104	-5%	-$6.22M	0.03%	501
2026 Q1	$115M	Buy	1,350,706 +88,629	+7%	+$7.9M	0.04%	459
2025 Q4	$100M	Sell	1,262,077 -249,169	-16%	-$19.5M	0.03%	505
2025 Q3	$121M	Buy	1,511,246 +37,026	+3%	+$3.16M	0.04%	432
2025 Q2	$134M	Sell	1,474,220 -63,768	-4%	-$5.82M	0.05%	371
2025 Q1	$144M	Buy	1,537,988 +81,551	+6%	+$7.3M	0.05%	323
2024 Q4	$132M	Buy	+1,456,437	New	+$139M	0.05%	346

Other funds holding CL

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Raymond James Financial's CL Position: Q3 2026 in Review

Raymond James Financial increased its Colgate-Palmolive (CL) stake by 1.2% in Q3 2026, buying an estimated $1.35M and bringing the position to 1,294,562 shares worth $110M. The position accounts for 0.03% of the portfolio, ranked #517.

Raymond James Financial first reported a position in CL in Q4 2024 and has held it in 8 quarters since. The position peaked at $144M in Q1 2025. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

Raymond James Financial held 1,294,562 shares of Colgate-Palmolive worth $110M as of Q3 2026.
Raymond James Financial bought 14,960 Colgate-Palmolive shares in Q3 2026, an estimated $1.35M.
Colgate-Palmolive made up 0.03% of Raymond James Financial's portfolio in Q3 2026, its #517 holding.
Raymond James Financial first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 8 quarters since.
Raymond James Financial's Colgate-Palmolive position peaked at $144M in Q1 2025.
1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.